http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9205140-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52436e0808c4a16ce7b705cf2b03fccf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d51a3bbd3fa1ddc931c4f18ecd02cb9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3fdf4f15f63ad075a76de39c5102fe2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a09caafad9a84d78b638415a865e907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77894d862657fd6a22691a7553d604b5
publicationDate 2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9205140-B2
titleOfInvention MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
abstract Described is a vaccine for prevention and treatment of cancer characterized by microsatellite instability (MSI). The vaccine contains an MSI-specific frameshift peptide (FSP) generating humoral and cellular responses against tumor cells or a nucleic acid encoding said FSP. The vaccine of the present invention is particularly useful for the prevention/treatment of colorectal cancer, endometrial cancer, gastric cancer or small bowel cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682402-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017340717-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578109-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484581-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11168121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9732131-B2
priorityDate 2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005239070-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03087162-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9958552-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226487904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27924

Total number of triples: 32.